DoW Breast Cancer, Clinical Research Extension Award

The DoW Breast Cancer, Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The award aims to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Key features of this award include: • The research team must include two or more breast cancer consumer advocates. • The funding mechanism allows for a single Principal Investigator (PI) or two partnering PIs. • The award supports research in breast cancer clinical studies. • The application must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.